This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (37)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Viral Infections  • Infectious Diseases, Other  • Immunization  • Alert me on articles by topic  Social Bookmarking   What's this?

Impact on Mortality and Influenza-Associated Morbidity

Bettie C. G. Voordouw, MD, MPH; Paul D. van der Linden, PharmD, PhD; Simon Simonian, PhD; Johan van der Lei, MD, PhD; Miriam C. J. M. Sturkenboom, PharmD, PhD; Bruno H. C. Stricker, MD, PhD

Arch Intern Med. 2003;163:1089-1094.

Background  Influenza-related morbidity and mortality have been extensively studied with hospital and reimbursement data. However, little is known about the effectiveness of the annual vaccination programs in generally healthy community-dwelling elderly. The objective of our study was to investigate the effectiveness of influenza vaccination in community-dwelling elderly during the 1996 to 1997 influenza epidemic.

Methods  We performed a population-based cohort study using the computerized Integrated Primary Care Information database in the Netherlands. Subjects who were 65 years and older in 1996 with a permanent status in a practice in the source population were considered eligible for study participation. Two cohorts were defined on the basis of vaccination status. We estimated and compared all-cause mortality, pneumonia, and clinical influenza infection rates between the cohorts.

Results  Influenza vaccination was associated with a significant reduction of morbidity and mortality in vaccinated elderly (relative risk [RR], 0.72; 95% confidence interval [CI], 0.60-0.87). Influenza infections decreased significantly in the vaccinated population (RR, 0.48; 95% CI, 0.26-0.91). Mortality was reduced significantly in elderly with comorbidity (RR, 0.67; 95% CI, 0.48-0.94). The risk reduction for pneumonia was nonsignificant (RR, 0.77; 95% CI, 0.55-1.07) but was temporally related to the peak influenza activity.

Conclusions  In this study, influenza vaccination was associated with decreased mortality and influenza infections in community-dwelling elderly. Our results indicate that, in a season of mild influenza activity and good antigenic match between vaccine strains and circulating strains, influenza vaccination reduced mortality in the vaccinated population. Our data support an annual vaccination strategy for all community-dwelling elderly.

From the Pharmaco-epidemiology Unit, Departments of Internal Medicine and Epidemiology & Biostatistics (Drs Voordouw, van der Linden, Sturkenboom, and Stricker) and Department of Medical Informatics (Drs van der Lei and Sturkenboom), Erasmus Medical Centre, Rotterdam, the Netherlands; Medicines Evaluation Board, the Hague, the Netherlands (Drs Voordouw and Simonian); and Department of Drugs and Medical Devices, Inspectorate for Health Care, the Hague (Dr Stricker). The authors have no relevant financial interest in this article.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Influenza Vaccination and Mortality: Differentiating Vaccine Effects From Bias
Fireman et al.
Am J Epidemiol 2009;170:650-656.
ABSTRACT | FULL TEXT  

Annual influenza vaccination in community-dwelling elderly individuals and the risk of lower respiratory tract infections or pneumonia.
Voordouw et al.
Arch Intern Med 2006;166:1980-1985.
ABSTRACT | FULL TEXT  

Clinical Effectiveness of First and Repeat Influenza Vaccination in Adult and Elderly Diabetic Patients
Looijmans-Van den Akker et al.
Diabetes Care 2006;29:1771-1776.
ABSTRACT | FULL TEXT  

Evidence of bias in estimates of influenza vaccine effectiveness in seniors
Jackson et al.
Int J Epidemiol 2006;35:337-344.
ABSTRACT | FULL TEXT  

Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors
Jackson et al.
Int J Epidemiol 2006;35:345-352.
ABSTRACT | FULL TEXT  

Pharmacists' role in increasing pneumococcal and influenza vaccination
Sokos
Am J Health Syst Pharm 2005;62:367-377.
ABSTRACT | FULL TEXT  

Clinical Effectiveness of Influenza Vaccination in Persons Younger Than 65 Years With High-Risk Medical Conditions: The PRISMA Study
Hak et al.
Arch Intern Med 2005;165:274-280.
ABSTRACT | FULL TEXT  

Annual Revaccination Against Influenza and Mortality Risk in Community-Dwelling Elderly Persons
Voordouw et al.
JAMA 2004;292:2089-2095.
ABSTRACT | FULL TEXT  

Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people
Armstrong et al.
BMJ 2004;329:660.
ABSTRACT | FULL TEXT